Celgene, the U.S multinational biopharmaceutical company, was founded in 1980. Its goal is to build a major global biopharmaceutical corporation focused on discovering, developing and commercializing innovative therapies to treat cancer and inflammation through gene and protein regulation. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.

Celgene’s operations are now spread throughout the U.S as a globally integrated and culturally diverse biopharmaceutical company with more than 1,600 employees worldwide.